Ira M. Lubin - Concepedia

Author

Ira M. Lubin

Centers for Disease Control and Prevention ORCID

Also Known As

I M Lubin, I.M. Lubin, Ira Lubin, Ira M Lubin, Ira M. Lubin, Lubin, Ira M, Ogino, Shuji, Shuji Ogino

Publications

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention University of Utah ARUP Laboratories (United States)Quest Diagnostics (United States)Emory University

About

Ira M. Lubin is an author at Centers for Disease Control and Prevention specializing in medicine, genetics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	510
2	Public Health	6	6	299
3	Engineering	1	1	59
4	Natural Sciences	1	1	12
5	Nursing	1	1	17

Ira M. Lubin

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas William K. Funkhouser, Ira M. Lubin, Federico A. Monzon, Journal of Molecular Diagnostics	2012	184
Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing Iris Schrijver, Nazneen Aziz, Daniel H. Farkas, Journal of Molecular Diagnostics	2012	149
Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII John F. Healey, Ira M. Lubin, Hiroaki Nakai, Journal of Biological Chemistry	1995	134
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting Cecelia Bellcross, Sara Bedrosian, Elvan Daniels, Genetics in Medicine Cancer EpidemiologyGastrointestinal OncologyCancer ScreeningMedicineColorectal Cancer	2012	91
Attitudes of clinicians following large-scale pharmacogenomics implementation Josh F. Peterson, Julie R. Field, Yaping Shi, The Pharmacogenomics Journal Personalized TreatmentPharmacogenomicsPharmacogeneticsPublic HealthMedicine	2015	83
Residues Glu2181-Val2243 Contain a Major Determinant of the Inhibitory Epitope in the C2 Domain of Human Factor VIII John F. Healey, Rachel T. Barrow, Hiba M. Tamim, Blood	1998	82
Reporting Incidental Findings in Genomic Scale Clinical Sequencing—A Clinical Laboratory Perspective Madhuri Hegde, Sherri J. Bale, Pınar Bayrak‐Toydemir, Journal of Molecular Diagnostics SequencingIncidental FindingsMedicineGeneticsNext-generation Sequencing	2015	61
Developing a Sustainable Process to Provide Quality Control Materials for Genetic Testing Bin Chen, Catherine D. O’Connell, D. Joe Boone, Genetics in Medicine Genetic TestingEngineeringGenetic TechnologyGeneticsBiotechnology	2005	59
Clinician Perspectives about Molecular Genetic Testing for Heritable Conditions and Development of a Clinician-Friendly Laboratory Report Ira M. Lubin, Margaret M. McGovern, Zoe Gibson, Journal of Molecular Diagnostics Genetic AnalysisGenetic TestingPrenatal Genetic TestingGeneticsBiostatistics	2009	53
Public health impact of genetic tests at the end of the 20th century Paula W. Yoon, Bin Chen, Andrew Faucett, Genetics in Medicine	2001	49

Page 1